References
- G. B. D. Diarrhoeal Disease Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018. doi:https://doi.org/10.1016/S1473-3099(18)30362-1.
- Troeger C, Colombara DV, Rao PC, Khalil IA, Brown A, Brewer TG, Guerrant RL, Houpt ER, Kotloff KL, Misra K, et al.. Global disability-adjusted life-year estimates of long-term health burden and undernutrition attributable to diarrhoeal diseases in children younger than 5 years. Lancet Glob Health. 2018;6:e255–e269. doi:https://doi.org/10.1016/S2214-109X(18)30045-7.
- Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T, Armah G, Bines JE, Brewer TG, Colombara DV, et al.. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172:958–965. doi:https://doi.org/10.1001/jamapediatrics.2018.1960.
- World Health Organization. Rotavirus vaccines: an update. Wkly Epidemiol Rec. 2009;84:533–540.
- Abou-Nader AJ, Sauer MA, Steele AD, Tate JE, Atherly D, Parashar UD, et al.. Global rotavirus vaccine introductions and coverage: 2006–2016. Hum Vaccin Immunother. 2018;14:2281–2296. doi:https://doi.org/10.1080/21645515.2018.1470725.
- Department of Health. 2014 Philippine Health Statistics. 2016; [ accessed 2018 Oct 26]. https://www.doh.gov.ph/sites/default/files/publications/2014PHS_PDF.pdf.
- Adkins HJ, Escamilla J, Santiago LT, Ranoa C, Echeverria P, Cross JH. Two-year survey of etiologic agents of diarrheal disease at San Lazaro Hospital, Manila, Republic of the Philippines. J Clin Microbiol. 1987;25:1143.
- Arciaga MR, Santana-Arciaga RT, Cristobal FL, Nazareth B, Roces MCR, Grafil I, et al.. Community response to a rotavirus diarrhea outbreak in Zamboanga City. West Mindanao Health Res J. 2002;3:33–47.
- Bravo LC, Saniel MC, Rogacion JM, Santos-Ocampo PD. Enteropathogens in acute diarrhea: clinical indicators. Phil J Pediatr. 1989;38:78–83.
- Lucero MG, Saniel MC, Geronimo JG, Ang CV, Leano FT, Mate RB, et al.. Etiology of diarrhea in hospitalized children. Phil J Microbiol Infect Dis. 1984;13:17–24.
- Paje-Villar E, Co BG, Carandang EH, Raymundo A, Lagamayo E, Hart CA, et al.. Diarrheas among Filipino infants and children: clinical and laboratory correlations. Santo Tomas J Med. 1992;41:53–63.
- San Pedro MC, Walz SE. A comprehensive survery of pediatric diarrhea at a private hospital in Metro Manila. Southeast Asian J Trop Med Public Health. 1991;22:203.
- Saniel MC. Prospective study of diarrhea in infants and young children of a peri-urban Philippine community: morbidity patterns and etiologies. Trans Nat Aca Sci Tech Philipp. 1986;8:183–187.
- Saniel MC, Moriles RR, Monzon OT, Salazar NP, Leano FT, Trajano EC, Sombrero LT, Mate RB, Villanueva JA, Geronimo JE. The relative importance of various enteropathogens in the etiology of acute diarrhea: a hospital-based study in urban Philippines. 14th SEAMIC Workshop; 1988; Tokyo (Japan).
- Santos MIBL, Daag J, Bravo LC. Rotavirus acute gastroenteritis among Filipino children in year 2001. Pediatr Infect Dis Soc Philipp J. 2002;6:11–19.
- Villa F. The prevalence and clinical profile of rotavirus diarrhea in a community hospital. Phil J Pediatr. 1994;43:183–187.
- Carlos CC, Inobaya MT, Bresee JS, Lagrada ML, Olorosa AM, Kirkwood CD, et al.. The burden of hospitalizations and clinic visits for rotavirus disease in children aged <5 years in the Philippines. J Infect Dis. 2009;200(Suppl 1):S174–81.doi:https://doi.org/10.1086/605044.
- Fischer Walker CL, Black RE. Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size. BMC Public Health. 2011;11(Suppl 3):S16. doi:https://doi.org/10.1186/1471-2458-11-S3-S16.
- World Health Organization Department of Immunization Vaccines and Biologicals. Generic protocol for monitoring impact of rotavirus vaccination of gastroenteritis disease. Geneva (Switzerland): World Health Organization; 2008.
- National Statistical Coordination Board. Poverty statistics: Agusan del Sur. Manila, Philippines: Philippine Statistical Authority; 2010.
- Lopez AL, Daag JV, Esparagoza J, Bonifacio J, Fox K, Nyambat B, Parashar UD, Ducusin MJ, Tate JE. Effectiveness of monovalent rotavirus vaccine in the Philippines. Sci Rep. 2018;8:14291. doi:https://doi.org/10.1038/s41598-018-32595-9.
- Lopez AL, Raguindin PF, Esparagoza J, Fox K, Batmunkh N, Bonifacio J, Parashar UD, Tate JE, Ducusin MJ. Impact of rotavirus vaccine on diarrheal hospitalization and outpatient consultations in the Philippines: first evidence from a middle-income Asian country. Vaccine. 2018;36:3308–3314. doi:https://doi.org/10.1016/j.vaccine.2018.04.058.
- Soares-Weiser K, MacLehose H, Ben-Aharon I, Goldberg E, Pitan F, Cunliffe N. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Sys Rev. 2010;5. doi:https://doi.org/10.1002/14651858.CD008521.
- Burnett E, Jonesteller CL, Tate JE, Yen C, Parashar UD. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from Diarrhea. J Infect Dis. 2017;215:1666–1672. doi:https://doi.org/10.1093/infdis/jix186.
- Hungerford D, Vivancos R, Read JM, Iturriza-Gomicronmara M, French N, Cunliffe NA. Rotavirus vaccine impact and socioeconomic deprivation: an interrupted time-series analysis of gastrointestinal disease outcomes across primary and secondary care in the UK. BMC Med. 2018;16. doi:https://doi.org/10.10.1186/s12916-017-0989-z.
- UNICEF Supply Division. Rotavirus vaccine: supply & demand update. 2016; [ accessed 2018 Oct 28]. https://www.unicef.org/supply/files/Rotavirus_Vaccine_Supply_and_Demand_Update_-_October_2016.pdf.
- Lee I-H, Standaert B, Nievera MC, Jossie. R. Cost-effectiveness analysis of universal mass vaccination of Rotarix in the Philippines. PIDSPJ. 2014;15:15–29. http://www.pidsphil.org/journal_summary.php?id=178.
- Lam HY, Wu DB, Rivera AS, Alejandria MM, Velasco GN, Sison OT, Ladia MA, Mantaring JB, Santillan M. Assessing the cost-effectiveness of a Universal Rotavirus Vaccination program for the Philippines using a dynamic transmission model. Value Health. 2015;18:A225. doi:https://doi.org/10.1016/j.jval.2015.03.1308.
- Amarasinghe A, Davison L, Diorditsa S. Engagement of private providers in immunization in the Western Pacific region. Vaccine. 2018;36:4958–4962. doi:https://doi.org/10.1016/j.vaccine.2018.01.008.
- MIMS Philipppines. Rotarix and Rotateq. 2018; [ accessed Oct 28]. https://www.mims.com.
- Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, et al.. Efficacy of a monovalent human- bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014;383:2136–2143. doi:https://doi.org/10.1016/S0140-6736(13)62630-6.
- Kulkarni PS, Desai S, Tewari T, Kawade A, Goyal N, Garg BS, Kumar D, Kanungo S, Kamat V, Kang G, et al.. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants. Vaccine. 2017;35:6228–6237. doi:https://doi.org/10.1016/j.vaccine.2017.09.014.
- Isanaka S, Guindo O, Langendorf C, Matar Seck A, Plikaytis BD, Sayinzoga-Makombe N, McNeal MM, Meyer N, Adehossi E, Djibo A, et al.. Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger. N Engl J Med. 2017;376:1121–1130. doi:https://doi.org/10.1056/NEJMoa1609462.
- UNICEF Supply Division. Vaccine price data. 2016; [ accessed 2018 Oct 28]. https://www.unicef.org/supply/files/180705_Rota.pdf.
- Deen J, Lopez AL, Kanungo S, Wang XY, Anh DD, Tapia M, Grais RF. Improving rotavirus vaccine coverage: can newer-generation and locally produced vaccines help? Hum Vaccin Immunother. 2018;14:495–499. doi:https://doi.org/10.1080/21645515.2017.1403705.